Lurasidone for the treatment of depressive symptoms in schizophrenia: analysis of 4 pooled, 6-week, placebo-controlled studies

OBJECTIVE: Depressive symptoms are common in schizophrenia and can worsen outcomes and increase suicide risk. Lurasidone is an atypical antipsychotic agent indicated for the treatment of schizophrenia and for the treatment of major depressive episodes associated with bipolar I disorder. This post ho...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:CNS Spectr
Main Authors: Nasrallah, Henry A., Cucchiaro, Josephine B., Mao, Yongcai, Pikalov, Andrei A., Loebel, Antony D.
Formato: Artigo
Idioma:Inglês
Publicado em: Cambridge University Press 2014
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4411643/
https://ncbi.nlm.nih.gov/pubmed/24955752
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1017/S1092852914000285
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados